JP2019503171A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019503171A5 JP2019503171A5 JP2018532655A JP2018532655A JP2019503171A5 JP 2019503171 A5 JP2019503171 A5 JP 2019503171A5 JP 2018532655 A JP2018532655 A JP 2018532655A JP 2018532655 A JP2018532655 A JP 2018532655A JP 2019503171 A5 JP2019503171 A5 JP 2019503171A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- nagal
- human
- polypeptide
- replaced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15202729 | 2015-12-24 | ||
| EP15202729.8 | 2015-12-24 | ||
| PCT/EP2016/082304 WO2017109034A1 (en) | 2015-12-24 | 2016-12-22 | Human alpha-n-acetylgalactosaminidase polypeptide |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019503171A JP2019503171A (ja) | 2019-02-07 |
| JP2019503171A5 true JP2019503171A5 (cg-RX-API-DMAC10.html) | 2020-02-06 |
| JP6956417B2 JP6956417B2 (ja) | 2021-11-02 |
Family
ID=55129455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018532655A Expired - Fee Related JP6956417B2 (ja) | 2015-12-24 | 2016-12-22 | ヒトα−Ｎ−アセチルガラクトサミニダーゼポリペプチド |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11040114B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3393501B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP6956417B2 (cg-RX-API-DMAC10.html) |
| KR (1) | KR20180088919A (cg-RX-API-DMAC10.html) |
| CA (1) | CA3008975A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2017109034A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20180088919A (ko) * | 2015-12-24 | 2018-08-07 | 옥시레인 유케이 리미티드 | 인간 알파-n-아세틸갈락토사미니다아제 폴리펩티드 |
| WO2019051297A1 (en) * | 2017-09-08 | 2019-03-14 | The Nemours Foundation | AGENT, DEVICE AND BLOOD CIRCULATION SYSTEM FOR TREATING LYSOSOMAL DISEASES, AND METHODS OF TREATING LYSOSOMAL DISEASES |
| EP3773702A2 (en) | 2018-04-05 | 2021-02-17 | CureVac AG | Novel yellow fever nucleic acid molecules for vaccination |
| WO2021222232A1 (en) * | 2020-04-28 | 2021-11-04 | The Trustees Of The University Of Pennsylvania | Compositions and uses thereof for treatment of angelman syndrome |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4879231A (en) | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
| US4929555A (en) | 1987-10-19 | 1990-05-29 | Phillips Petroleum Company | Pichia transformation |
| US20020123476A1 (en) | 1991-03-19 | 2002-09-05 | Emanuele R. Martin | Therapeutic delivery compositions and methods of use thereof |
| US5587308A (en) | 1992-06-02 | 1996-12-24 | The United States Of America As Represented By The Department Of Health & Human Services | Modified adeno-associated virus vector capable of expression from a novel promoter |
| US6806084B1 (en) | 1992-06-04 | 2004-10-19 | The Regents Of The University Of California | Methods for compositions for in vivo gene delivery |
| US5478745A (en) | 1992-12-04 | 1995-12-26 | University Of Pittsburgh | Recombinant viral vector system |
| EP0922109A1 (en) | 1996-05-21 | 1999-06-16 | Novo Nordisk A/S | Novel yeast promoters suitable for expression cloning in yeast and heterologous expression of proteins in yeast |
| US20060014264A1 (en) | 2004-07-13 | 2006-01-19 | Stowers Institute For Medical Research | Cre/lox system with lox sites having an extended spacer region |
| WO2006129080A1 (en) | 2005-05-31 | 2006-12-07 | The Institute Of Cancer Research: Royal Cancer Hospital | Materials and methods for transducing cells with a viral vector |
| JP4368925B2 (ja) * | 2005-11-18 | 2009-11-18 | 財団法人 東京都医学研究機構 | 基質特異性を変換した新規高機能酵素 |
| JP5967861B2 (ja) | 2007-04-03 | 2016-08-10 | オキシレイン ユーケー リミテッド | 分子のグリコシル化 |
| US8569032B2 (en) * | 2007-05-18 | 2013-10-29 | Tokyo Metropolitan Institute Of Medical Science | Proteins having acquired A-galactosidase activity |
| KR102000383B1 (ko) * | 2009-09-29 | 2019-07-15 | 유니버시테이트 젠트 | 만노스-1-포스포-6-만노스 결합의 포스포-6-만노스로의 가수분해 |
| BR112013007616B1 (pt) | 2010-09-29 | 2023-01-24 | Oxyrane Uk Limited | Métodos para retirar o cap ("uncapping") de porções de manose-1- fosfo-6-manose e desmanosilar n-glicanos fosforilados em uma glicoproteína, para direcionar uma glicoproteína para o interior de uma célula de mamífero, e para converter uma glicoproteína de uma primeira forma que não se liga substancialmente a um receptor de manose-6-fosfato em uma segunda forma que se liga substancialmente a um receptor de manose-6-fosfato em uma célula de mamífero |
| CA2867237C (en) | 2012-03-15 | 2024-01-02 | Wouter Vervecken | Methods and materials for treatment of pompe's disease |
| CA2970638A1 (en) * | 2014-12-22 | 2016-06-30 | Codexis, Inc. | Human alpha-galactosidase variants |
| KR20180088919A (ko) * | 2015-12-24 | 2018-08-07 | 옥시레인 유케이 리미티드 | 인간 알파-n-아세틸갈락토사미니다아제 폴리펩티드 |
-
2016
- 2016-12-22 KR KR1020187021246A patent/KR20180088919A/ko not_active Abandoned
- 2016-12-22 CA CA3008975A patent/CA3008975A1/en active Pending
- 2016-12-22 JP JP2018532655A patent/JP6956417B2/ja not_active Expired - Fee Related
- 2016-12-22 US US16/063,408 patent/US11040114B2/en not_active Expired - Fee Related
- 2016-12-22 EP EP16831567.9A patent/EP3393501B1/en active Active
- 2016-12-22 WO PCT/EP2016/082304 patent/WO2017109034A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6396415B2 (ja) | コレステロールレベルを変更する組成物および方法 | |
| US20250154490A1 (en) | Mutant cytidine deaminases with improved editing precision | |
| RU2010122053A (ru) | Иммуносупрессорные полипептиды и нуклеиновые кислоты | |
| JP2019033757A (ja) | 核タンパク質の産生のための修飾ポリヌクレオチド | |
| PE20190352A1 (es) | Proteinas de fusion gdf 15 y usos de estas | |
| NZ602351A (en) | Axmi-115, axmi-113, axmi-005, axmi-163 and axmi-184 : vip3a insecticidal proteins from bacillus thuringiensis and methods for their use | |
| CN113811317B (zh) | 突变vsv胞外域多肽及其用途 | |
| SA522433360B1 (ar) | L-أَسْباراجيناز مُعدل | |
| JP2018510623A (ja) | Ｎｋｇ２ｄ及び腫瘍関連抗原に対する二価抗体 | |
| WO2011036443A3 (en) | Si protease c- terminal polypeptides and uses thereof for treating inflammation or coagulation disorders | |
| IL288541B (en) | Vaccine against rsv | |
| JP2013542913A5 (cg-RX-API-DMAC10.html) | ||
| FI3256579T3 (fi) | Kysteiiniproteaasi | |
| US20230075095A1 (en) | Polypeptides and their use | |
| UA110599C2 (uk) | Пептид для імунотерапії пухлин, включаючи нейрональні пухлини та пухлини мозку | |
| WO2009100934A9 (en) | Identification of a novel cysteine-rich cell penetrating peptide | |
| IN2012DN02981A (cg-RX-API-DMAC10.html) | ||
| JP2014506450A5 (cg-RX-API-DMAC10.html) | ||
| EP4083058A2 (en) | Delivery constructs for transcytosis and related methods | |
| MX376466B (es) | Vectores de expresion para una secrecion de proteina mejorada. | |
| FI4034555T3 (fi) | Dap10/dap12-fuusiopolypeptidit | |
| EP4021479A2 (en) | Modified tff2 polypeptides | |
| WO2024121790A3 (en) | Cas12 protein, crispr-cas system and uses thereof | |
| ZA202304029B (en) | Cxcl9 and variants thereof for immunotherapy of cancer diseases | |
| WO2010007144A3 (en) | Mutated netrin-4 proteins, fragments thereof and their uses as drugs |